THE LYME TIMBER COMPANY LLC other names

{{ Info.Overview }}
Revenue: {{ Info.Revenue | formatUSD }} Headquarters: {{ Info.Headquarters }}

Adviser Profile

As of Date:

03/15/2024

Adviser Type:

- Large advisory firm


Number of Employees:

18 5.88%

of those in investment advisory functions:

9 12.50%


Registration:

SEC, Approved, 8/20/2014

AUM:

738,640,908 -1.56%

of that, discretionary:

0

Private Fund GAV:

0 -100.00%

Avg Account Size:

82,071,212 20.31%


SMA’s:

YES

Private Funds:

0 1

Contact Info

603 xxxxxxx

Websites :
Client Types:

+

Advisory Activities:

+

Compensation Arrangments:

+

Reported AUM

Discretionary
Non-discretionary
1B 1B 871M 697M 523M 349M 174M
2015 2016 2017 2018 2019 2020 2021 2022 2023

Recent News

Why Are Pharmaceutical Companies Gradually Abandoning Vaccines?
04/02/2021

For example, the Lyme vaccine, licensed by the FDA in 1998, was not covered by the program. After licensure, many people claimed that the Lyme vaccine caused chronic arthritis as well as muscle ...

medscape.com

Stonington finance board finalizes budget for referendum vote
04/01/2021

He also read a letter from former First Selectmen Rob Simmons, who urged the board to fully fund a $40,400 position to hire a community outreach specialist for the Human Services Department to ...

theday.com

With $16 Million Gift, Columbia Establishes Treatment Center and Clinical Trials Network for Lyme and Tick-Borne Diseases
03/30/2021

A new center that will provide specialized care for patients with Lyme disease and other tick-borne diseases will begin seeing patients this summer

miragenews.com

Columbia establishes treatment center, clinical trials network for Lyme disease
03/30/2021

With a $16 million gift from the Steven & Alexandra Cohen Foundation, Columbia will open a center for Lyme and other tick-borne diseases this summer, offering patients specialized care and expanding research at a national level.

eurekalert.org

Ammonite review: Audacious romance rocks with passion
03/27/2021

As far as we know, the Lyme Regis fossil collector was God-fearing and romantically unattached. Here, Mary (Kate Winslet; awesome) doesn’t dwell on the divine, swears like a trooper and is gay.

MSN

Could the Jurassic Coast become Britain's new gay getaway after Ammonite release?
03/26/2021

Sites like the Lyme Regis Museum built on the site of Anning’s home could experience the same interest Gentleman Jack setting Shibden Hall, which recorded a 300% rise in visitors in 2019.

telegraph.co.uk

Private Funds



Employees




Brochure Summary

Overview

The Lyme Timber Company LLC is an investment advisory firm specializing in advisory services related to investments in timberlands and other rural real estate. Lyme was founded in 2008 by James Hourdequin, Thomas Morrow, and Peter Stein to continue the business of Lyme’s predecessor, The Lyme Timber Company, LP (subsequently renamed LTC Partners LP), which was founded in 1976. LTC Partners LP initially retained a minority interest in Lyme and then sold that interest to Lyme in 2021. Lyme is 100% owned by its employees, and as of the date hereof, James Hourdequin, David Hoffer, Thomas Morrow, Sean Ross, Peter Stein, and Sarah Kitz (the “Principals”) collectively own over 90% of Lyme. In meeting each client’s needs, Lyme follows a disciplined and value-oriented investment philosophy with the goal of achieving attractive risk-adjusted returns. We have expertise in the careful selection, management, and disposition of timberland and rural real estate, including lands with important conservation values. We have extensive experience in the negotiation and sale of working forest conservation easements and implementation of carbon offset projects that restrict development on lands but allow income generation from sources such as sustainable timber harvesting, recreational leasing activities, and the sale of ecosystem services. Lyme seeks to sell conservation easements and other interests early in the investment cycle to help enhance investment performance of the client portfolios we manage while reducing real estate exposure and risk for the clients. We also have expertise structuring advantageous debt arrangements (e.g. New Markets Tax Credit financings), restructuring forestry and timber operations, and developing and managing wetland and stream mitigation banks. Lyme provides investment advisory services to pooled investment vehicles (each a “Fund” and collectively, the “Funds”). In addition, Lyme provides management services to a separately managed account (the “SMA” and together with the Funds,
the “Clients”) based on the terms set forth in the relevant management agreement. We tailor our advisory services to the specified investment mandates of our Clients, consistent with the Client’s governing documents, which may include a private placement memorandum, limited partnership agreement, management agreement, and/or subscription agreement (individually and collectively, the “Governing Documents”). Because we are committed to adhering to a specialized investment strategy, we do not otherwise generally permit investors in the Funds to impose restrictions on our ability to invest. Our Funds’ objective is to generate capital appreciation and income through investments in timberland, ranch and agricultural land, rural real estate, and related assets. We believe that our experience, knowledge, and use of multiple conservation sale strategies can help achieve attractive risk-adjusted returns. Specifically, we focus on the following key objectives: 1. Seek attractive investment returns through disciplined valuation, conservation sales, and/or operational restructuring. 2. Pursue conservation-related investment strategies that help to mitigate speculative real estate exposure and risk. 3. When prudent, and subject to limitations in the Governing Documents, seek to utilize advantageous financing to enhance equity returns. 4. Seek to enhance Fund-level returns through careful investment in emerging ecosystem service opportunities, such as wetland, stream and endangered species mitigation banking. 5. Work to maintain strong investment discipline with the Principals involved in all investments. As of December 31, 2023, we managed approximately $738,640,908 in regulatory assets under management, all on a non-discretionary basis. We have indicated that Lyme provides non- discretionary advice because Lyme’s investment advice is subject to the approval of each Fund’s general partner. However, please note that each Fund’s general partner is a related person and under common control with Lyme.